Processa Pharmaceuticals ... (PCSA)
0.50
-0.05 (-8.93%)
At close: Mar 03, 2025, 3:59 PM
0.49
-1.90%
After-hours: Mar 03, 2025, 06:15 PM EST
Processa Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -11.12M | -27.42M | -11.43M | -14.41M | -3.36M | -3.77M | -1.86M | -337.18K | -2.98M | -4.53M | -3.07M | -2.44M | -940K | -160K |
| Depreciation & Amortization | 222.00 | 788.5K | 790.97K | 803.77K | 803.77K | 630.09K | 1.86K | 159.00 | 238.82K | 461.26K | 414.91K | 108.47K | n/a | n/a |
| Stock-Based Compensation | 1.06M | 8.83M | 3.41M | 2.73M | 510.48K | 74.06K | n/a | 6.69K | 96.93K | 231.52K | 216.08K | 457K | n/a | n/a |
| Other Working Capital | 621.14K | 434.96K | -1.08M | -385.48K | 36.78K | -52.71K | 151.14K | 288.58K | -58.16K | 58.16K | -7.54K | -39.35K | 2.48M | n/a |
| Other Non-Cash Items | 1.39M | 7.66M | 220.61K | 8.88M | 75.91K | 67.07K | 38.7K | 967.00 | 83.3K | 153.62K | 216.08K | 457K | -2.24M | n/a |
| Deferred Income Tax | n/a | n/a | -530.61K | -1M | -602.72K | -902.8K | n/a | 7.92K | 1.54M | 1.21M | -216.08K | -453.5K | n/a | n/a |
| Change in Working Capital | 605.21K | 543.6K | -1.18M | -140.39K | -179.71K | 188.71K | 161.13K | 278.24K | 153.5K | -228.46K | -101.06K | -14.93K | 2.47M | n/a |
| Operating Cash Flow | -8.06M | -9.61M | -8.72M | -3.14M | -2.75M | -3.71M | -1.65M | -43.2K | -871.91K | -2.7M | -2.54M | -1.89M | -710K | -160K |
| Capital Expenditures | -2.78K | n/a | n/a | n/a | n/a | -20.5K | -20.62K | -23.77K | -1.4K | -48.3K | -27.67K | -334.34K | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | -1.78K | 6.28K | 17K | 31.1K | 3.35K | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -1.78K | 1.02M | 17K | 41.6K | n/a | n/a | n/a | -2.5M | n/a |
| Investing Cash Flow | -2.78K | n/a | n/a | n/a | n/a | -22.28K | 1M | 17K | 40.2K | -44.94K | -27.67K | -334.34K | -2.5M | n/a |
| Debt Repayment | n/a | n/a | n/a | 862.46K | 805K | n/a | 2.58M | 15K | 733.1K | 1.7M | 383.1K | -1.37M | 2.5M | n/a |
| Common Stock Repurchased | n/a | -388.84K | -64.4K | -95.21K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.5M | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -52.75K | n/a | -186.49K | n/a | 895.72K | -250.96K | -154.8K | n/a | n/a | 509.96K | 1.35M | 1.82M | -4K | 160K |
| Financial Cash Flow | 6.27M | -388.84K | 9.8M | 17.87M | 1.7M | 2.62M | 2.43M | 15K | 821.1K | 2.57M | 1.73M | 453.38K | 6M | 160K |
| Net Cash Flow | -1.8M | -9.99M | 1.08M | 14.72M | -1.05M | -1.11M | 1.78M | -11.2K | -10.6K | -165.63K | -834.61K | -1.77M | 2.79M | n/a |
| Free Cash Flow | -8.07M | -9.61M | -8.72M | -3.14M | -2.75M | -3.73M | -1.68M | -66.98K | -873.3K | -2.74M | -2.57M | -2.22M | -710K | -160K |